Author’s Note and update
President Donald Trump has been given the new antiviral drug Remdesivir at the Walter Reed National Military Medical Center in Bethesda, Maryland following a COVID-19 diagnosis.
“The president was given the first dose of remdesivir Friday evening and will be on a five-day course of the IV drug, his physician, Dr. Sean Conley, said during a news conference Saturday.”
On May 22, Remdesivir for the Treatment of Covid-19 — Preliminary Report by National Institute of Allergy and Infectious Diseases, National Institutes of Health, was published by the New England Journal of Medicine, (NEJM)
On June 29, 2020, Dr. Anthony Fauci, who is the head of NIAID granted the “Greenlight” to Gilead Sciences Inc. despite the fact that the study of the new experimental drug was “preliminary”.The NIH-NIAID sponsored report (May 22) was used to justify a major agreement with Gilead Sciences Inc.
A $1.6 billion agreement between the HHS and Gilead Sciences Inc. was announced on June 29th, despite the fact that NIH NIAID study published in the NEJM was considered “preliminary”. In the late 1990s, Gilead Sciences Inc was headed by Donald Rumsfeld (1997-2001), who later joined the George W. Bush administration as Secretary of Defense (2001-2006).
The article below was first published in the week following the June 29 decision.
Michel Chossudovsky, Global Research, October 4, 2020
There is an ongoing battle to suppress Hydroxychloroquine (HCQ), a cheap and effective drug for the treatment of Covid-19. The campaign against HCQ is carried out through slanderous political statements, media smears, not to mention an authoritative peer reviewed “evaluation” published on May 22nd by The Lancet, which was based on fake figures and test trials.
The study was allegedly based on data analysis of 96,032 patients hospitalized with COVID-19 between Dec 20, 2019, and April 14, 2020 from 671 hospitals Worldwide. The database had been fabricated. The objective was to kill the Hydroxychloroquine (HCQ) cure on behalf of Big Pharma.
While The Lancet article was retracted, the media casually blamed “a tiny US based company” named Surgisphere whose employees included “a sci-fi writer and adult content model” for spreading “flawed data” (Guardian).